Blood markers may predict death risk in crush syndrome
NCT ID NCT07433127
First seen Feb 25, 2026 · Last updated Apr 30, 2026 · Updated 12 times
Summary
This study looked at 325 adults with crush syndrome in the intensive care unit to see if certain blood tests could predict who might die within 28 days. Researchers checked inflammation markers like neutrophil-to-lymphocyte ratio and compared them to standard severity scores. The goal was to find a simple way to identify high-risk patients early. No new treatment was tested; this was an observational study using past medical records.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ataturk University Research Hospital
Erzurum, 20100, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.